<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> is a hallmark in many <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> like <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> or vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Cholesterol and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> are both vascular risk factors which have been associated with <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:mp ids='MP_0001845'>inflammation</z:mp> and blood-brain barrier dysfunction </plain></SENT>
<SENT sid="2" pm="."><plain>In previous studies we found that <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> but not <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> induced <z:mp ids='MP_0001845'>inflammation</z:mp> in rats in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of the present study was to investigate the effect of a combined treatment of Sprague Dawley rats with cholesterol and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> for 5 months on spatial learning and memory, blood-brain barrier integrity and <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Cholesterol treated rats showed severe learning deficits, while rats treated with cholesterol and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (Mix) counteracted the cholesterol-induced <z:mp ids='MP_0001845'>inflammation</z:mp> and partly the cortical blood-brain barrier disruptions, although cognition was still impaired </plain></SENT>
<SENT sid="5" pm="."><plain>To study the potential protective effect of <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, <z:mp ids='MP_0001845'>inflammation</z:mp> was induced in organotypic rat brain cortex slices and primary microglial cells by treatment with different inflammatory stimuli (e.g. <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> or tissue plasminogen activator) </plain></SENT>
<SENT sid="6" pm="."><plain>Tissue plasminogen activator-induced <z:mp ids='MP_0001845'>inflammation</z:mp> was counteracted by <z:chebi fb="0" ids="17230">homocysteine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, our data demonstrate that <z:chebi fb="0" ids="17230">homocysteine</z:chebi> significantly ameliorates cholesterol-induced <z:mp ids='MP_0001845'>inflammation</z:mp> and blood-brain barrier disruption but not the <z:hpo ids='HP_0002354'>memory impairment</z:hpo>, possibly involving a tissue plasminogen activator-related mechanism </plain></SENT>
</text></document>